Cerevel Therapeutics

+$0.48 (+1.78%) As of 5:42 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERE and other ETFs, options, and stocks.

About CERE

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease.

CEO
N. Anthony Coles
Employees
200
Headquarters
Cambridge, Massachusetts
Founded
2018

CERE Key Statistics

Market cap
4.06B
Price-Earnings ratio
—
Dividend yield
—
Average volume
516.79K
High today
$28.24
Low today
$26.27
Open price
$26.86
Volume
137.40K
52 Week high
$46.16
52 Week low
$12.01

CERE Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure